JAGUAR HEALTH INC
JAGXNASDAQTrading Snapshot
- Day Range
- $0.77 – $0.79
- 52-Week Range
- $0.82 – $92.75
- Volume
- $2.00B
- Avg Volume
- $1.95B
- Shares Outstanding
- 4.9M
- Next Earnings
- Sep 8, 2026
Fundamentals Snapshot
- Annual Revenue
- $28M
- Last Q Revenue
- $7M
- P/E Ratio
- —
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-713.94
- Dividend Yield
- —
Why Investors Own JAGX
- ✓High-growth profile — revenue up -9.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 42% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About JAGUAR HEALTH INC
A company profile for JAGUAR HEALTH INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Jaguar Health’s Napo Pharma Satisfies Conditions Required To Receive Payment Of Non-Dilutive $2M Holdback Amount From Future Pak Related To US Commercial Licensing Agreement
As announced, Jaguar received an upfront payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's two commercialized
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market session. The market value of their outstanding shares is at $1.5 million. CalciMedica (NASDAQ:CALC) shares rose 9.8%
Jaguar Health Says Findings Of Exploratory Surveys Of Dog Owners And Veterinary Oncologists Support Commercial Opportunity For Neonorm Dog, New Extension Of Jaguar's Neonorm Franchise
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regular session. The market value of their outstanding shares is at $1.8 billion. The company's, Q2 earnings came out
Jaguar Health Portfolio Company Napo Pharmaceuticals Provides Its Novel Crofelemer Powder To Treat Intestinal Failure From Microvillus Inclusion Disease In The EU For Compassionate Use
As announced, Napo has previously provided crofelemer powder for oral solution to treat select infant and pediatric IF patients with MVID in relevant expanded access programs in the U.S. under Single-Patient
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market session. The market value of their outstanding shares is at $112.9 million. Barinthus Biotherapeutics (NASDAQ:BRNS)